Standard BioTools Inc.
LAB
$1.50
$0.074.90%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 108.25M | 110.79M | 111.52M | 112.95M | 94.42M |
| Total Other Revenue | -- | -- | -- | 921.00K | 921.00K |
| Total Revenue | 108.25M | 110.79M | 111.52M | 112.95M | 94.42M |
| Cost of Revenue | 66.03M | 65.92M | 68.17M | 71.73M | 61.75M |
| Gross Profit | 42.22M | 44.87M | 43.35M | 41.22M | 32.67M |
| SG&A Expenses | 122.11M | 119.98M | 116.74M | 113.33M | 97.09M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 209.37M | 207.72M | 206.48M | 206.69M | 173.33M |
| Operating Income | -101.12M | -96.93M | -94.96M | -93.74M | -78.91M |
| Income Before Tax | -108.47M | -97.37M | -104.50M | -97.30M | -83.44M |
| Income Tax Expenses | -1.67M | -338.00K | 310.00K | 542.00K | 108.00K |
| Earnings from Continuing Operations | -106.80 | -97.03 | -104.81 | -97.84 | -83.54 |
| Earnings from Discontinued Operations | -21.45M | -23.47M | -27.96M | -41.05M | -41.05M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -128.25M | -120.50M | -132.76M | -138.89M | -124.59M |
| EBIT | -101.12M | -96.93M | -94.96M | -93.74M | -78.91M |
| EBITDA | -87.40M | -78.44M | -76.07M | -73.83M | -59.04M |
| EPS Basic | -0.34 | -0.32 | -0.36 | -0.55 | -0.71 |
| Normalized Basic EPS | -0.16 | -0.14 | -0.14 | -0.15 | -0.20 |
| EPS Diluted | -0.34 | -0.32 | -0.36 | -0.55 | -0.71 |
| Normalized Diluted EPS | -0.16 | -0.14 | -0.14 | -0.15 | -0.20 |
| Average Basic Shares Outstanding | 1.52B | 1.50B | 1.50B | 1.41B | 1.12B |
| Average Diluted Shares Outstanding | 1.52B | 1.50B | 1.50B | 1.41B | 1.12B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |